Case Series Study of the Efficacy of Compounded Antibacterial, Steroid, and Moisturizer in Atopic Dermatitis

Fatima Lakhani, Kachiu Lee, Peter A. Lio*

*Corresponding author for this work

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background/Objectives: Previous studies have demonstrated that the use of a topical antimicrobial combined with a steroid may benefit patients with atopic dermatitis (AD), but modern guidelines discourage the use of antimicrobials in treating this condition. We sought to evaluate the degree of improvement in the severity and extent of AD lesions after using a compounded antibacterial, steroid, and moisturizer (CASM). Methods: This was a nonblinded retrospective review of patients with AD treated using CASM. Multiple patients in the study had previously failed mid- or higher-potency topical steroids, systemic immunosuppressives, or phototherapy (standard therapy [ST] group). Patients were assessed at baseline and at one follow-up visit, with an average follow-up period of 49.5 days. We included all patients with AD in the database who were prescribed CASM and had one subsequent follow-up appointment. We excluded patients who had newly started a systemic immunosuppressant or phototherapy at the time of beginning CASM. Results: We included 116 patients in the study. We observed a decrease in mean severity of 1.4 points on a 6-point scale and an average decrease in body surface area (BSA) affected of 23.2 ± 2.5% overall and a decrease in mean severity of 1.4 points and average decrease in BSA affected of 19.7 ± 2.8% in the ST group. Conclusion: CASM appears to be effective in the management of AD and may offer additional benefit for patients who have plateaued with standard therapies.

Original languageEnglish (US)
Pages (from-to)322-325
Number of pages4
JournalPediatric dermatology
Volume34
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Atopic Dermatitis
Steroids
Phototherapy
Body Surface Area
Immunosuppressive Agents
Group Psychotherapy
Appointments and Schedules
Databases
Guidelines

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Dermatology

Cite this

@article{01199da0d8844b439d634c947be507ae,
title = "Case Series Study of the Efficacy of Compounded Antibacterial, Steroid, and Moisturizer in Atopic Dermatitis",
abstract = "Background/Objectives: Previous studies have demonstrated that the use of a topical antimicrobial combined with a steroid may benefit patients with atopic dermatitis (AD), but modern guidelines discourage the use of antimicrobials in treating this condition. We sought to evaluate the degree of improvement in the severity and extent of AD lesions after using a compounded antibacterial, steroid, and moisturizer (CASM). Methods: This was a nonblinded retrospective review of patients with AD treated using CASM. Multiple patients in the study had previously failed mid- or higher-potency topical steroids, systemic immunosuppressives, or phototherapy (standard therapy [ST] group). Patients were assessed at baseline and at one follow-up visit, with an average follow-up period of 49.5 days. We included all patients with AD in the database who were prescribed CASM and had one subsequent follow-up appointment. We excluded patients who had newly started a systemic immunosuppressant or phototherapy at the time of beginning CASM. Results: We included 116 patients in the study. We observed a decrease in mean severity of 1.4 points on a 6-point scale and an average decrease in body surface area (BSA) affected of 23.2 ± 2.5{\%} overall and a decrease in mean severity of 1.4 points and average decrease in BSA affected of 19.7 ± 2.8{\%} in the ST group. Conclusion: CASM appears to be effective in the management of AD and may offer additional benefit for patients who have plateaued with standard therapies.",
author = "Fatima Lakhani and Kachiu Lee and Lio, {Peter A.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1111/pde.13141",
language = "English (US)",
volume = "34",
pages = "322--325",
journal = "Pediatric Dermatology",
issn = "0736-8046",
publisher = "Wiley-Blackwell",
number = "3",

}

Case Series Study of the Efficacy of Compounded Antibacterial, Steroid, and Moisturizer in Atopic Dermatitis. / Lakhani, Fatima; Lee, Kachiu; Lio, Peter A.

In: Pediatric dermatology, Vol. 34, No. 3, 01.05.2017, p. 322-325.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Case Series Study of the Efficacy of Compounded Antibacterial, Steroid, and Moisturizer in Atopic Dermatitis

AU - Lakhani, Fatima

AU - Lee, Kachiu

AU - Lio, Peter A.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Background/Objectives: Previous studies have demonstrated that the use of a topical antimicrobial combined with a steroid may benefit patients with atopic dermatitis (AD), but modern guidelines discourage the use of antimicrobials in treating this condition. We sought to evaluate the degree of improvement in the severity and extent of AD lesions after using a compounded antibacterial, steroid, and moisturizer (CASM). Methods: This was a nonblinded retrospective review of patients with AD treated using CASM. Multiple patients in the study had previously failed mid- or higher-potency topical steroids, systemic immunosuppressives, or phototherapy (standard therapy [ST] group). Patients were assessed at baseline and at one follow-up visit, with an average follow-up period of 49.5 days. We included all patients with AD in the database who were prescribed CASM and had one subsequent follow-up appointment. We excluded patients who had newly started a systemic immunosuppressant or phototherapy at the time of beginning CASM. Results: We included 116 patients in the study. We observed a decrease in mean severity of 1.4 points on a 6-point scale and an average decrease in body surface area (BSA) affected of 23.2 ± 2.5% overall and a decrease in mean severity of 1.4 points and average decrease in BSA affected of 19.7 ± 2.8% in the ST group. Conclusion: CASM appears to be effective in the management of AD and may offer additional benefit for patients who have plateaued with standard therapies.

AB - Background/Objectives: Previous studies have demonstrated that the use of a topical antimicrobial combined with a steroid may benefit patients with atopic dermatitis (AD), but modern guidelines discourage the use of antimicrobials in treating this condition. We sought to evaluate the degree of improvement in the severity and extent of AD lesions after using a compounded antibacterial, steroid, and moisturizer (CASM). Methods: This was a nonblinded retrospective review of patients with AD treated using CASM. Multiple patients in the study had previously failed mid- or higher-potency topical steroids, systemic immunosuppressives, or phototherapy (standard therapy [ST] group). Patients were assessed at baseline and at one follow-up visit, with an average follow-up period of 49.5 days. We included all patients with AD in the database who were prescribed CASM and had one subsequent follow-up appointment. We excluded patients who had newly started a systemic immunosuppressant or phototherapy at the time of beginning CASM. Results: We included 116 patients in the study. We observed a decrease in mean severity of 1.4 points on a 6-point scale and an average decrease in body surface area (BSA) affected of 23.2 ± 2.5% overall and a decrease in mean severity of 1.4 points and average decrease in BSA affected of 19.7 ± 2.8% in the ST group. Conclusion: CASM appears to be effective in the management of AD and may offer additional benefit for patients who have plateaued with standard therapies.

UR - http://www.scopus.com/inward/record.url?scp=85019627305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019627305&partnerID=8YFLogxK

U2 - 10.1111/pde.13141

DO - 10.1111/pde.13141

M3 - Article

VL - 34

SP - 322

EP - 325

JO - Pediatric Dermatology

JF - Pediatric Dermatology

SN - 0736-8046

IS - 3

ER -